Approximately 80% cases of human breast cancers (HBCs) are estrogen receptor positive (ER+), and ~ 20% are ER− (estrogen receptor negative) (Deandrea et al., 2008; MacMahon, 2006; Suzuki et al., 2008). Here, ESR1 is linked to breast carcinoma.